iShares Biotechnology ETF (IBB) |
| 172.18 -0.06 (-0.03%) 05-29 16:00 |
| Open: | 172.408 |
| High: | 172.91 |
| Low: | 171.53 |
| Volume: | 1,396,923 |
| Market Cap: | 8,015(M) |
| PE Ratio: | 22.83 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 203.52 |
| Resistance 1: | 174.25 |
| Pivot price: | 169.38 |
| Support 1: | 166.85 |
| Support 2: | 162.28 |
| 52w High: | 179.64 |
| 52w Low: | 120.33 |
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 26 May 2026
iShares Biotechnology ETF (IBB) Latest Announcement & Press Release - Moomoo
Fri, 22 May 2026
IBB Stock Price, Quote & Chart | ISHARES BIOTECHNOLOGY ETF (NASDAQ:IBB) - ChartMill
Tue, 28 Apr 2026
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Tue, 21 Apr 2026
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
Tue, 07 Apr 2026
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026 - 24/7 Wall St.
Sat, 21 Mar 2026
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
